The total daily draw is 0.1 mL, making the vial last 10 days as well but with much smaller injection volumes and a higher margin for error on the measuring side
Liraglutide (Victoza, Saxenda) Approved for obesity at higher doses, typically results in 57% weight loss
This can be especially appealing for patients who are nervous about nausea, have a history of medication sensitivity, are close to their goal weight, want help with food noise rather than aggressive weight loss, or prefer a more conservative plan
This would make retatrutide widely available as a prescription medication with standardized dosing and quality controls
Activation of GLP-1 Receptor Enhances the Chemosensitivity of Pancreatic Cancer Cells
GLP-1 analogues have been shown in clinical trials to improve metabolic health and significantly reduce body weight